Optimal control analysis of a leukemia model under imatinib treatment

I.R. Rădulescu, D. Cândea and A. Halanay

Mathematics and Computers in Simulation (MATCOM), 2016, vol. 121, issue C, 1-11

Abstract: The paper is devoted to the study of a mathematical model of drug therapy for Chronic Myelogenous Leukemia (CML). The disease dynamics are given by a couple of delay differential equations that describe the interaction between a stem-like population of CML cells and a more mature, differentiated one, without self-renewal properties. A molecular targeted therapy, such as Imatinib, is considered. The objective is to minimize the size of the tumoral cells’ mass while minimizing the amount of drug (thus, minimizing both the adverse effects and the costs). The optimal control is calculated using a discretization scheme. The results are supported by numerical simulations.

Keywords: Leukemia; Asymmetric division; Delay differential system; Optimal control; Discretization (search for similar items in EconPapers)
Date: 2016
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0378475415001135
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:matcom:v:121:y:2016:i:c:p:1-11

DOI: 10.1016/j.matcom.2015.03.002

Access Statistics for this article

Mathematics and Computers in Simulation (MATCOM) is currently edited by Robert Beauwens

More articles in Mathematics and Computers in Simulation (MATCOM) from Elsevier
Bibliographic data for series maintained by Catherine Liu ().